Susquehanna International Group, LLP Outset Medical, Inc. Call Options Transaction History

Susquehanna International Group, LLP

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$0.45 - $4.82 $9,270 - $99,292	20,600 New	20,600 $14,000
Q4 2023 Feb 14, 2024	BUY	$3.07 - $10.25 $93,021 - $310,575	30,300 New	30,300 $163,000
Q3 2022 Nov 14, 2022	SELL	$14.67 - $21.7 $82,152 - $121,520	-5,600 Reduced 29.17%	13,600 $217,000
Q2 2022 Aug 15, 2022	SELL	$13.46 - $48.16 $129,216 - $462,335	-9,600 Reduced 33.33%	19,200 $285,000
Q1 2022 May 16, 2022	SELL	$34.22 - $47.24 $290,870 - $401,540	-8,500 Reduced 22.79%	28,800 $1.31 Million
Q4 2021 Feb 14, 2022	BUY	$43.29 - $58.77 $662,337 - $899,181	15,300 Added 69.55%	37,300 $1.72 Million
Q3 2021 Nov 15, 2021	BUY	$36.86 - $54.98 $810,920 - $1.21 Million	22,000 New	22,000 $1.09 Million

19.9M

66.8K

60.3K

Ticker OM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 48,007,300
Market Cap $54.2M
Description
Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It provides the Tablo Hemodialysis System, which comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was ...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.